MTOR and type 2 diabetes mellitus: In conclusion, further investigation into how metformin suppresses signalling through the mTOR/p70S6K pathway may lead to new therapeutic intervention strategies to prevent unwanted bone marrow adipogenesis associated with diseases, such as T2DM, where bone health is impaired.